title: Maternal serum alpha-fetoprotein and human chorionic gonadotropin levels in women with human immunodeficiency virus.
abstract: OBJECTIVE
  The purpose of this study was to establish whether there is a correlation between maternal serum genetic screen analyte results in pregnant women with human immunodeficiency virus and corresponding human immunodeficiency virus index values.
  
  
  METHODS
  Medical records of all pregnant women with human immunodeficiency virus who were delivered at Bronx Lebanon Hospital Center from January 2000 through December 2001 were reviewed for maternal serum screen results, viral load, CD4 counts and percent, antiretroviral therapy, opportunistic infections, substance abuse, and other demographic data. Statistical analysis was accomplished with the chi(2) test, Mann-Whitney U test, and Spearman rank correlation test, with a probability value of <.05 considered significant.
  
  
  RESULTS
  Of the 98 women with human immunodeficiency virus who were delivered, 49 women (50%) had a maternal serum genetic screen available. Screened and unscreened women had similar severity of human immunodeficiency virus disease, CD4 count and percentage, and viral loads. Serum screen results showed elevations in maternal serum human chorionic gonadotropin (1.43 +/- 1.04 multiples of the median [MoM]; range, 0.2-5.2 MoM) and maternal serum alpha-fetoprotein (1.29 +/- 0.9 MoM; range, 0.5-3.3 MoM) compared with expected values in the general obstetric population. Maternal serum human chorionic gonadotropin was correlated inversely with CD4 count (P =.002) and CD4 percent (P <.0001). Maternal serum alpha-fetoprotein varied directly with viral load (P <.0001).
  
  
  CONCLUSIONS
  Increasing maternal serum human chorionic gonadotropin and maternal serum alpha-fetoprotein levels in patients with human immunodeficiency virus are correlated with increasing viral load and decreasing CD4 counts.
authors.affiliation: Department of Obstetrics and Gynecology, Bronx Lebanon Hospital Center, New York, USA. Suedoc1@aol.com
authors.forename: Susan
authors.initials: S
authors.lastname: Gross
authors.forename: Wilfrido
authors.initials: W
authors.lastname: Castillo
authors.forename: Marilyn
authors.initials: M
authors.lastname: Crane
authors.forename: Bialines
authors.initials: B
authors.lastname: Espinosa
authors.forename: Suzanne
authors.initials: S
authors.lastname: Carter
authors.forename: Richard
authors.initials: R
authors.lastname: DeVeaux
authors.forename: Carolyn
authors.initials: C
authors.lastname: Salafia
mesh_terms: D000328:Adult; D018791:CD4 Lymphocyte Count; D006063:Chorionic Gonadotropin / Q000097:blood*; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000821:virology; D006801:Humans; D011247:Pregnancy / Q000097:blood*; D011251:Pregnancy Complications, Infectious / Q000097:blood* / Q000821:virology; D019562:Viral Load; D000509:alpha-Fetoproteins / Q000032:analysis*
chemical_list: D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins